Close Menu

NEW YORK ─ There is a steady pipeline of new tests for SARS-CoV-2 coming onto the market, but clinicians might be at a loss to determine not only their efficacy but their optimal use cases. To answer these questions the UK National Institute for Health Research will bankroll a new multicenter project across the country to assess how tests perform in hospitals, general practitioners' officers, and in care homes. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.